Peer-reviewed studies relevant to AOD-9604 are listed in the Citations tab on this product page
However, sermorelin is preferred over recombinant growth hormone as it causes fewer side effects
Upper/Lower Gastrointestinal Symptoms Adverse event reporting databases, RCTs, and real-world data consistently show that GLP-1 RAs are commonly associated with GI symptoms such as nausea, vomiting, diarrhea, constipation, abdominal pain, and dyspeptic complaints
PMID: 20554713 | doi:10.1210/jc.2010-0490 Leggett J et al
While it hasnt been approved for weight loss, some physicians prescribe it to help their patients lose weight
Current clinical evidence suggests associations with reductions in body weight and AHI, along with improved glycemic control, although these benefits appear largely mediated by metabolic effects